Annovis Bio, Inc. (ANVS) Stock
NYSE · ANVS
1.19
Fundamentals
Market cap
$48.65M
Price / Earnings ratio
-1.0x
Price / Sales ratio
N/A
Price / Book ratio
-11.4x
Return on assets
-2.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Annovis Bio, Inc.
No description available.
SectorHealthcare
IndustryBiotechnology
Employees7
CEODr. Maria L. Maccecchini Ph.D.
IPO DateNov 18, 2021
HeadquartersMalvern, PA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Maria L. Maccecchini Ph.D. | Founder, Acting CFO, CEO, President & Executive Director | 1951 |
| Dr. Cheng Fang Ph.D. | Chief Scientific Officer | — |
| Ms. Eve M. Damiano M.S., RAC | Senior Vice President of Regulatory Operations | — |
| Mr. Blake Jensen M.B.A. | Head of Quality | — |
| Ms. Hilda Maibach | Senior Vice President of Statistics | — |
Fundamentals
Valuation
Market cap$48.65M
Price-to-sales ratioN/A
Price-to-book value-11.42
Price-earnings ratio-1.00
Return on Equity-318.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.79
Income Statement
Average volume1,292,703
EBITDA$-40.92M
1 year high (52w)$5.50
1 year low (52w)$1.04
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



